^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

COMPANY:
Devyser

i
Other names: Devyser
Related tests:
Evidence

News

3ms
Illumina, Devyser diagnostics ink IVD development agreement (360Dx)
"Devyser Diagnostics said on Monday that it has entered into an in vitro diagnostic development agreement with Illumina...The agreement will enable Sweden-based Devyser to advance its next-generation sequencing-based IVD tests on the Illumina MiSeqDx sequencer through regulatory processes in the US and in Europe. Financial and other terms were not disclosed."
Licensing / partnership
7ms
Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research (Genomeweb)
"Swedish molecular diagnostics firm Devyser Diagnostics said on Wednesday that it has entered an agreement with Thermo Fisher Scientific to promote its laboratory services to pharmaceutical companies."
Licensing / partnership
10ms
Devyser launches two new genetic testing solutions for hereditary cancer (PRNewswire)
"Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits offer efficient, targeted, and confident analysis of genes associated with increased cancer risk, such as those involved in Lynch syndrome, and in breast and ovarian cancers."
Launch
|
Devyser BRCA PALB2 NGS • Devyser LynchFAP
11ms
Devyser's clinical laboratory receives CLIA certification (PRNewswire)
"Devyser...announcing that the company's clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification. This certification allows the Devyser US lab to begin testing on patient samples...Certification of the Devyser lab under CLIA enables highly useful testing for hereditary diseases, oncology, and post-transplant follow-up." "
Regulatory
2years
Shuwen Biotech announce agreement with Devyser to commercialize breast cancer tests in China (Shuwen Biotech Press Release)
"Shuwen Biotech...today announces that it has entered into a distribution agreement with Devyser Diagnostics...to market and support Devyser BRCA NGS and other oncology kits in China. Under the terms of the agreement, Shuwen will distribute the Devyser kits in China and also offer testing and NGS data analysis services with the Devyser kits in its CAP-accredited clinical labs in China."
Licensing / partnership
|
Devyser BRCA NGS